Bushe, C, Sobanski, E, Coghill, D, Berggren, L, De Bruyckere, K, Leppämäki, S.
Post Hoc Analysis of Potential Predictors of Response to Atomoxetine for the Treatment of Adults with Attention-Deficit/Hyperactivity Disorder using an Integrated Database.
CNS Drugs
30(4)
:
317 -334
2016
view publication
Inglis, SK, Carucci, S, Garas, P, Häge, A, Banaschewski, T, Buitelaar, JK, Dittmann, RW, Falissard, B, Hollis, C, Kovshoff, H, et al.
Prospective observational study protocol to investigate long-term adverse effects of methylphenidate in children and adolescents with ADHD: the Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects (ADDUCE) study.
BMJ Open
6(4)
:
e010433
2016
view publication
Otero, IH, Banaschewski, T, Nagy, P, Soutullo, CA, Zuddas, A, Caballero, B, Geibel, B, Yan, B, Coghill, DR.
Time-course of treatment-emergent adverse events in a long-term safety study of lisdexamfetamine dimesylate in children and adolescents with ADHD.
European Psychiatry
33(S1)
:
s132
2016
view publication
Coghill, D, Hodgkins, P.
Health-related quality of life of children with attention-deficit/hyperactivity disorder versus children with diabetes and healthy controls.
European Child & Adolescent Psychiatry
25(3)
:
261 -271
2016
view publication
Nagy, P, Häge, A, Coghill, DR, Caballero, B, Adeyi, B, Anderson, CS, Sikirica, V, Cardo, E.
Functional outcomes from a head-to-head, randomized, double-blind trial of lisdexamfetamine dimesylate and atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder and an inadequate response to methylphenidate.
European Child & Adolescent Psychiatry
25(2)
:
141 -149
2016
view publication
